National Health Investors (NYSE:NHI) Issues Quarterly Earnings Results

Key Points

• Mixed quarter: National Health Investors reported GAAP EPS of $0.82, missing consensus of $1.21, but revenue jumped ~28.9% year‑over‑year to $115.13 million and management highlighted strong operating/FFO performance.
• Guidance and stock reaction: Management set FY‑2026 EPS guidance of $4.740–4.790, below street estimates (~$5.02), and the stock traded down about 1.4% following the update.
• Income profile and capital deployment: NHI declared a $0.92 quarterly dividend (annualized yield ~4.9% with a 121.85% payout ratio) and deployed $106.9 million to acquire seven properties aimed at supporting future rental/FFO growth.

National Health Investors (NYSE:NHI - Get Free Report) posted its quarterly earnings results on Monday. The real estate investment trust reported $0.82 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.21 by ($0.39), FiscalAI reports. The business had revenue of $115.13 million for the quarter, compared to the consensus estimate of $70.22 million. National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.National Health Investors's quarterly revenue was up 28.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.15 earnings per share. National Health Investors updated its FY 2026 guidance to 4.740-4.790 EPS.

National Health Investors Stock Down 1.4%

Shares of NYSE:NHI opened at $75.66 on Tuesday. The business's 50 day moving average is $83.79 and its 200 day moving average is $80.56. National Health Investors has a 12-month low of $68.80 and a 12-month high of $91.38. The stock has a market cap of $3.67 billion, a price-to-earnings ratio of 25.05, a PEG ratio of 4.18 and a beta of 0.55. The company has a quick ratio of 6.90, a current ratio of 6.90 and a debt-to-equity ratio of 0.76.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors's payout ratio is currently 121.85%.

Analyst Upgrades and Downgrades

NHI has been the topic of a number of research reports. National Bank Financial set a $85.00 target price on shares of National Health Investors in a research report on Tuesday, January 20th. Wells Fargo & Company reduced their price target on shares of National Health Investors from $86.00 to $84.00 and set an "equal weight" rating for the company in a report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft lowered shares of National Health Investors from a "buy" rating to a "hold" rating and set a $85.00 price objective on the stock. in a report on Tuesday, January 20th. Truist Financial cut their price objective on shares of National Health Investors from $92.00 to $89.00 and set a "buy" rating on the stock in a research report on Wednesday, April 22nd. Finally, Cantor Fitzgerald restated an "overweight" rating and issued a $94.00 target price on shares of National Health Investors in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $87.50.

Key National Health Investors News

Here are the key news stories impacting National Health Investors this week:

• Positive Sentiment: Q1 operating results and FFO beat — NHI reported FFO/EPS of $1.24 for Q1, above consensus $1.21, with revenue up ~28.9% year‑over‑year (driven by recent transactions and portfolio performance). This supports current earnings quality and cash flow. NHI Announces First Quarter 2026 Results
• Positive Sentiment: Dividend maintained and attractive yield — NHI declared a $0.92 quarterly dividend (annualized yield ~4.9%), reinforcing its income profile for REIT investors. NHI Announces the Second Quarter 2026 Dividend
• Positive Sentiment: Strategic portfolio deployment — NHI invested $106.9M to acquire seven properties (532 units) in Colorado, expanding its SHOP portfolio and backing future rental/FFO growth. NHI Announces $106.9 Million SHOP Investment
• Neutral Sentiment: Investor update and slide deck published — NHI released an updated investor presentation and a Q1 portfolio performance report to provide more transparency on operations and capital deployment; useful for modeling but not a catalyst by itself. NHI Issues Investor Update
• Neutral Sentiment: Analyst/industry commentary — Comparative write‑ups (e.g., head‑to‑head analyses) provide context versus peers but do not materially change fundamentals. Head-To-Head Analysis: National Health Investors & HG
• Negative Sentiment: FY‑2026 EPS guidance below consensus — Management set FY‑2026 EPS guidance at $4.740–4.790, below the street consensus (~$5.02). That guidance cut/softness is the primary reason investors are marking the stock down despite the quarter beat.

Institutional Investors Weigh In On National Health Investors

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. NewEdge Advisors LLC increased its position in shares of National Health Investors by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust's stock valued at $114,000 after purchasing an additional 345 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in National Health Investors by 9.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust's stock worth $18,460,000 after buying an additional 21,851 shares during the last quarter. Jane Street Group LLC increased its holdings in National Health Investors by 1,728.4% during the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust's stock worth $5,148,000 after buying an additional 65,885 shares during the last quarter. Cetera Investment Advisers raised its position in National Health Investors by 6.1% in the second quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust's stock worth $336,000 after acquiring an additional 275 shares during the period. Finally, American Century Companies Inc. raised its position in National Health Investors by 2.2% in the second quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust's stock worth $1,349,000 after acquiring an additional 420 shares during the period. Hedge funds and other institutional investors own 62.51% of the company's stock.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.